Depression linked to E-cigarettes and cigarette use among college students

Jul.15.2022
Depression linked to E-cigarettes and cigarette use among college students
Depression linked to tobacco use among college students, according to study in Psychiatry Research Communications.

A study published in the Journal of Psychiatric Research found a positive correlation between depression and tobacco product use, including electronic and traditional cigarettes, among college students.


This study analyzed data from the Fall 2020 cohort of the Healthy Minds Study, which collected information on the psychological health of undergraduate and graduate students, as well as sociodemographic covariates and other relevant factors. The online survey was distributed to 36 universities across the United States between September and December 2020. Five of these universities included drug use in the survey, resulting in a sample size of 2,115 for this study.


Attendees reported on individuals who exclusively use e-cigarettes, exclusively use traditional cigarettes, and those who use a combination of both. The symptoms of depression were measured using the Patient Health Questionnaire-9 (PHQ-9) for the participants. The PHQ-9 questionnaire scores the answers on a scale ranging from 0 to 27, with scores above 5 indicating possible depression.


The study measures societal norms surrounding tobacco use and perceptions of risks associated with tobacco use. In order to gauge societal norms, participants were asked to estimate the percentage of college students who smoke. Responses to questions about tobacco risks were measured on a scale of 1 to 4, with 1 indicating "no risk" and 4 indicating "high risk.


Using logistic regression analysis, this study examines the social norms of tobacco use among individuals with symptoms of depression, perceived risk of smoking, and those who use both traditional cigarettes and e-cigarettes.


The average age of participants was 23.41±7.84 years, with 43.8% being female and 85.6% being white. Participants reported that in the past 30 days, 22.38% only used e-cigarettes, 7.89% only used traditional cigarettes, and 2.72% used a combination of both.


A study has found that 33.1% of participants met the criteria for possible depression, with an average score of 8.00 ± 6.33. The levels of depression were higher among all groups who used tobacco products: those who only used e-cigarettes (OR, 1.08; 95%CI, 1.06-1.10), those who only smoked traditional cigarettes (OR, 1.09; 95%CI, 1.06-1.12), and those who used both (OR, 1.05; 95%CI, 1.00-1.10).


Participants reported medium risks associated with smoking and vaping, with average scores of 3.26 ± 1.01 and 2.85 ± 0.98, respectively. The perceived social norms related to the use of electronic cigarettes (OR, 1.01; 95% CI 1.00-1.02) and cigarettes (OR, 1.02; 95% CI, 1.00-1.03) were higher and associated with increased use of these tobacco products.


Most participants in the study were white students, so the results may not be representative. Although the researchers emphasized the confidentiality of the responses, students may have underreported their tobacco use.


Overall, researchers have concluded that there is a link between depression and both e-cigarettes and traditional cigarettes. They have found that the likelihood of using e-cigarettes and traditional cigarettes is positively associated with the likelihood of depression.


The researchers stated that gaining further knowledge on psychosocial and mental health related factors could provide valuable information in understanding the smoking habits and associated risks in college students. This understanding can guide the development of smoking cessation policies.


I'm sorry, but without any text to translate, I cannot provide a response.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | ZAR Launches Coffee AirPouch, Expanding Pouch Format Into Caffeine Products
Product | ZAR Launches Coffee AirPouch, Expanding Pouch Format Into Caffeine Products
ZAR has introduced Coffee AirPouch, a nicotine-free caffeine pouch product that extends the brand’s AirPouch format into the functional consumer category. Each pouch contains 50mg of natural caffeine and features a coffee flavor, highlighting how pouch-based products are expanding beyond traditional nicotine applications into broader lifestyle and energy-use scenarios.
Market
Jul.13 by 2Firsts Perspectives
PMI Global R&D Chief Meets Chinese Tobacco Regulator as China Advances Heated Cigarette Standards
PMI Global R&D Chief Meets Chinese Tobacco Regulator as China Advances Heated Cigarette Standards
Philip Morris International’s global R&D chief Michele Cattoni met Liu Sanjiang, deputy director of China’s State Tobacco Monopoly Administration, in Beijing on Aug. 27. The meeting comes as China advances mandatory standards for heated cigarettes and nicotine pouches, laying groundwork for their domestic introduction. Cattoni has held senior roles in PMI’s heated tobacco development, while China’s draft standard covers multiple heating architectures, including systems similar in principle to PMI’s IQOS ILUMA technology.
Aug.27
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
Canadian Court Allows Juul and Altria Vape Class Action to Move Forward Over Youth Marketing Claims
Canadian Court Allows Juul and Altria Vape Class Action to Move Forward Over Youth Marketing Claims
A Quebec Superior Court has allowed a class action lawsuit against Juul Labs and Altria Group related to vaping products to proceed, involving allegations concerning marketing practices, youth exposure and corporate responsibility. The ruling only allows the case to move forward and does not represent a finding that Juul or Altria are legally liable. The case highlights continued legal risks facing vape companies regarding product marketing, youth protection and corporate accountability.
Jul.28
Product | SnowPlus Launches Nicotine-Free DASH in South Korea, Localising an Established Disposable Platform
Product | SnowPlus Launches Nicotine-Free DASH in South Korea, Localising an Established Disposable Platform
SnowPlus has introduced a nicotine-free version of DASH in South Korea, adapting an existing overseas disposable platform for the local market. The Korean version retains the series’ flat duckbill-style mouthpiece, ceramic heating architecture and disposable form factor while reducing nicotine content to 0%. By comparison, the overseas DASH 4000 platform typically features 7.5ml of prefilled e-liquid, up to 4,000 puffs and a 530mAh rechargeable battery, with nicotine-containing variants available in some markets. The product update centers on formulation localisation rather than a new hardware generation.
Aug.31
After Apple Business Decline, South Korea’s ITM Semiconductor Expands KT&G Vape Supply Chain as Vape Revenue Rises 24.8%
After Apple Business Decline, South Korea’s ITM Semiconductor Expands KT&G Vape Supply Chain as Vape Revenue Rises 24.8%
South Korean electronics component supplier ITM Semiconductor is reshaping its business portfolio after a decline in Apple-related protection circuit business, expanding its supply of vape devices and cartridges to KT&G. According to News1 on August 18, 2026, ITM’s vape-related revenue rose 24.8% year on year to 75.5 billion won in the first half of 2026. The company began mass production of vape devices at its Cikarang, Indonesia facility in January 2026, strengthening export manufacturing capacity. Meanwhile, Samsung-related protection circuit sales continued to grow, providing support during the transition.
Aug.20